The ongoing conflict in the Iran region is placing the United Kingdom on the brink of potential medicine shortages. Experts warn that if the situation persists, essential medications, including pain relievers and cancer treatments, could become scarce within weeks. Additionally, the prices of these crucial health products may see a significant rise.
Supply Chain Disruptions
The war has severely impacted the supply chain of vital raw materials, including oil, gas, fertilizers, and helium. David Weeks, a supply chain risk management director at Moody’s, describes this as a “perfect storm.” The closure of the Strait of Hormuz, a critical maritime route, complicates the export of pharmaceuticals from India, known as the world’s pharmacy due to its production of generic drugs and active pharmaceutical ingredients (APIs).
With significant disruptions reported at airports in Dubai, Doha, and Abu Dhabi, pharmaceutical companies are forced to reroute their shipments. Many are now relying on sea transport, which extends delivery times and exacerbates the situation. The primary shipping routes for medications are under immense pressure, raising concerns about the timely availability of health essentials.
Current Situation and Future Risks
Mark Samuels, CEO of Medicines UK, emphasizes that while there isn’t an immediate crisis, the situation is serious. He warns that if the conflict continues, drug shortages could emerge in just a few weeks. Typically, medical distributors maintain inventories for six to eight weeks, while hospital suppliers hold an additional two weeks.
The COVID-19 pandemic previously showcased the fragility of medicine availability, as essential drugs like paracetamol faced shortages due to increased demand and production challenges, particularly from India, which supplies 60% of global generic medicines.
Financial Implications on Supply
The US-Israel conflict has led to a sharp increase in air freight costs, with one in five NHS medicines transported by air. Samuels notes that manufacturers are currently absorbing these costs, but their low profit margins could lead to some medicines becoming unprofitable to supply. Although suppliers have long-term pricing agreements with NHS hospitals, they retain the ability to adjust prices for general practice and pharmacy medications, potentially passing increased costs onto consumers.
Expert Insights on Logistics
Wouter Dewulf, a logistics expert, points out that while medicine supplies are currently “disturbed,” they are not yet severely disrupted. He anticipates that drugmakers may implement single-digit price increases if conditions worsen. The duration of the conflict will significantly influence the extent of these price hikes.
Frank Van Gelder, a strategist in healthcare and pharma supply chains, highlights the impact of disrupted airspace in the Middle East. The region previously facilitated approximately 3,700 passenger flights daily, many of which also transported cargo. The drop in air cargo levels—down by 80% earlier this month—has severely affected the timely delivery of critical medications.
The Importance of Timely Transport
Certain medical products, including high-cost cancer treatments, gene therapies, and biologics requiring cold storage, depend on air transport for rapid delivery. Dewulf notes that healthcare cargo will receive priority over non-essential goods, yet the challenges remain significant.
For stable, generic medications, sea transport may serve as an alternative. However, the logistics of rerouting vessels around the Cape of Good Hope can add up to 14 days to shipping times and increase fuel costs significantly.
Broader Economic Effects
The rise in crude oil and natural gas prices has further implications. These increases affect the production costs of petrochemical products, essential for manufacturing APIs and medical supplies such as syringes and vials. Van Gelder emphasizes the cascading effects on the pharmaceutical industry, raising the question of who will ultimately bear these costs. The burden will likely fall on patients, either directly or through public health systems, ultimately funded by taxpayers.
Conclusion
As the conflict in Iran continues, the UK faces a precarious situation regarding its medicine supply chain. The ripple effects of geopolitical tensions are poised to impact not only the availability of essential medications but also their affordability. Stakeholders must remain vigilant and proactive in addressing these challenges to safeguard public health.
- Key Takeaways:
- The UK could face medicine shortages within weeks if the Iran conflict persists.
- Air transport disruptions have led to increased shipping costs for pharmaceuticals.
- The reliance on India for generic drugs poses additional risks to supply stability.
- Patients may ultimately bear the financial burden of rising medication costs.
Read more → www.theguardian.com